Literature DB >> 3590175

A case of glutaric aciduria type I with unique abnormalities in the cerebral CT findings.

S Yamaguchi, T Orii, K Yasuda, Y Kohno.   

Abstract

A first Japanese case of glutaric aciduria type I (GA-I) was described. She was a 7-month-old girl presenting with poor head control, irritability and sleeplessness. The profile of urinary organic acids by gas chromatography mass spectrometry (GC/MS) suggesting GA-I were confirmed by no activity of glutaryl-CoA dehydrogenase in the fibroblasts. The cerebral computer tomography (CT) showed marked changes such as large fluid collections on bilateral frontotemporal regions and a slight enlargement of bilateral ventricles. The amounts of urinary glutarate excretion decreased after restriction of lysine and tryptophan in her diet and administration of carnitine improved the carnitine levels in blood and urine, while these were less effective for the neurological symptoms. On the other hand, oral administration of lioresal, an analogue of gamma-aminobutyrate (GABA), cleared her symptoms such as ill temper, irritability and sleeplessness dramatically, and the abnormalities of the CT examinations were not more deteriorative until 2 years of her age at least. The neurological manifestations of GA-I seemed to be affected by the unusual metabolism of GABA in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3590175     DOI: 10.1620/tjem.151.293

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  2 in total

Review 1.  Diagnosis and management of glutaric aciduria type I.

Authors:  I Barić; J Zschocke; E Christensen; M Duran; S I Goodman; J V Leonard; E Müller; D H Morton; A Superti-Furga; G F Hoffmann
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

2.  Neuropathology in glutaric acidaemia type 1.

Authors:  C W Chow; E A Haan; S I Goodman; R M Anderson; W A Evans; B K Kleinschmidt-DeMasters; G Wise; J J McGill; D M Danks
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.